Implantable medical devices comprising bio-degradable alloys with enhanced degradation rates

Abstract

The invention provides medical devices comprising high-strength alloys which degrade over time in the body of a human or animal, at controlled degradation rates, without generating emboli and which have enhanced degradation due to the presence of a halogen component. In one embodiment the alloy is formed into a bone fixation device such as an anchor, screw, plate, support or rod. In another embodiment the alloy is formed into a tissue fastening device such as staple. In yet another embodiment, the alloy is formed into a dental implant or a stent.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This application is a continuation application of U.S. application Ser. No. 14,213,855, filed on Mar. 14, 2014, which claims the benefit of and priority to U.S. Provisional Application No. 61 / 785,531, filed on Mar. 14, 2013, the contents of each which are hereby incorporated by reference in their entireties for all purposes.FIELD OF THE INVENTION[0002]The present invention relates to biodegradable materials useful for manufacturing implantable medical devices, specifically biodegradable compositions comprising iron reactive component containing metal alloys that can provide high strength when first implanted and are gradually eroded and replaced with body tissue.BACKGROUND OF THE INVENTION[0003]Medical devices meant for temporary or semi-permanent implant are often made from stainless steel. Stainless steel is strong, has a great deal of load bearing capability, is reasonably inert in the body, does not dissolve in bodily fluids, and is du...

AI Technical Summary

Benefits of technology

The patent text describes an implantable medical device that has a design that maximizes the surface to mass ratio. This can lead to improved efficiency and performance of the device.

Problems solved by technology

Long lasting medical implants, however, are not always desirable.

Many devices for fixing bones become problematic once the bone has healed, requiring removal by means of subsequent surgery.

Similarly, short term devices such as tissue staples have to be removed after the tissue has healed, which limits their use internally.

However, none of the biodegradable polymeric materials developed to date have demonstrated sufficient strength to perform suitably when substantial loads must be carried by the material, when the material is required to plastically deform during implantation, or when any of the other native characteristic of metal are required from the material.

For example, the polyhydroxyalkanoate compositions described in U.S. Pat. No. 7,268,205 do not have sufficient strength on their own to bear weight and must be augmented by temporary fixation of bone segments.

In addition, biodegradable polymeric materials tend to lose strength far more quickly than they degrade, because the portions of the material under stress tend to be more reactive, causing preferential dissolution and breakdown at load-bearing regions.

Although ordinary steel compounds, unlike stainless steel, will degrade in biological fluids, they are not suitable for use in biodegradable implantable medical devices.

Rather, because of their large-grain structures, ordinary steels tend to break down by first degrading at grain boundaries, causing fissures and separations in the medical device, followed by rapid loss of strength and integrity and particulation.

Particulation of the medical device is extremely dangerous because it allows small pieces of the device to leave the area of implantation and become lodged in other tissues, where they can cause serious injury including organ failure, heart attack and stroke.

The use of ordinary steels in implantable medical devices is also complicated by the fact that ordinary steels typically contain alloying elements that are toxic when released in the body.